Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
CHRNA7 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P36544 |
|---|---|
| Clone Names | 100430243 |
| Gene ID | 1139;89832 |
|---|---|
| Other Names | Neuronal acetylcholine receptor subunit alpha-7, CHRNA7, NACHRA7 |
| Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13898a was selected from the N-term region of CHRNA7. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | CHRNA7 |
|---|---|
| Synonyms | NACHRA7 |
| Function | After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. The channel is blocked by alpha-bungarotoxin. |
| Cellular Location | Postsynaptic cell membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein. Note=TMEM35A/NACHO promotes its trafficking to the cell membrane (PubMed:27789755). RIC3 promotes its trafficking to the cell membrane (By similarity) {ECO:0000250|UniProtKB:Q05941, ECO:0000269|PubMed:27789755} |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The nicotinic acetylcholine receptors (nAChRs) are membersof a superfamily of ligand-gated ion channels that mediate fastsignal transmission at synapses. The nAChRs are thought to behetero-pentamers composed of homologous subunits. The proposedstructure for each subunit is a conserved N-terminal extracellulardomain followed by three conserved transmembrane domains, avariable cytoplasmic loop, a fourth conserved transmembrane domain,and a short C-terminal extracellular region. The protein encoded bythis gene forms a homo-oligomeric channel, displays markedpermeability to calcium ions and is a major component of brainnicotinic receptors that are blocked by, and highly sensitive to,alpha-bungarotoxin. Once this receptor binds acetylcholine, itundergoes an extensive change in conformation that affects allsubunits and leads to opening of an ion-conducting channel acrossthe plasma membrane. This gene is located in a region identified asa major susceptibility locus for juvenile myoclonic epilepsy and achromosomal location involved in the genetic transmission ofschizophrenia. An evolutionarily recent partial duplication eventin this region results in a hybrid containing sequence from thisgene and a novel FAM7A gene. Alternatively spliced transcriptvariants encoding different isoforms have been found for this gene.
References
Chernyavsky, A.I., et al. Am. J. Physiol., Cell Physiol. 299 (5), C903-C911 (2010) :Saccone, N.L., et al. Genes Brain Behav. 9(7):741-750(2010)Ruano, G., et al. Pharmacogenomics 11(7):959-971(2010)Jin, Y., et al. Int. J. Immunogenet. (2010) In press :Schraufstatter, I.U., et al. J Stem Cells 4(4):203-215(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Other Products
Shipping Information
